| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An intimate encounter: DC3s empower anti-tumor CTLs
|
Stojanovic, Ana
|
|
|
39 |
9 |
p. 1181-1183
|
article
|
| 2 |
ARTEMIS highlights VEGF inhibitors as effective partners for EGFR TKIs in EGFR mutant NSCLC
|
Le, Xiuning
|
|
|
39 |
9 |
p. 1178-1180
|
article
|
| 3 |
Bacteria and fungi: The counteracting modulators of immune responses to radiation therapy in cancer
|
Riquelme, Erick
|
|
|
39 |
9 |
p. 1173-1175
|
article
|
| 4 |
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study
|
Zhou, Qing
|
|
|
39 |
9 |
p. 1279-1291.e3
|
article
|
| 5 |
Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy
|
Shiao, Stephen L.
|
|
|
39 |
9 |
p. 1202-1213.e6
|
article
|
| 6 |
COVID-19 provides an opportunity to transform cancer research
|
Casolino, Raffaella
|
|
|
39 |
9 |
p. 1169-1170
|
article
|
| 7 |
High-frequency temperature monitoring for early detection of febrile adverse events in patients with cancer
|
Flora, Christopher
|
|
|
39 |
9 |
p. 1167-1168
|
article
|
| 8 |
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
|
Mairhofer, Mario
|
|
|
39 |
9 |
p. 1171-1172
|
article
|
| 9 |
Japan’s conditional early approval program for innovative cancer drugs: Comparison of the regulatory processes with the US FDA and the EMA
|
Murayama, Anju
|
|
|
39 |
9 |
p. 1165-1166
|
article
|
| 10 |
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity
|
Gozgit, Joseph M.
|
|
|
39 |
9 |
p. 1214-1226.e10
|
article
|
| 11 |
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity
|
Hutton, Colin
|
|
|
39 |
9 |
p. 1227-1244.e20
|
article
|
| 12 |
Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis
|
Tanaka, Kosuke
|
|
|
39 |
9 |
p. 1245-1261.e6
|
article
|
| 13 |
The Mediator captures CDK7, an attractive transcriptional target in cancer
|
Wang, Yubao
|
|
|
39 |
9 |
p. 1184-1186
|
article
|
| 14 |
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma
|
Seong, Bo Kyung A.
|
|
|
39 |
9 |
p. 1262-1278.e7
|
article
|
| 15 |
Tumor organoid-originated biomarkers predict immune response to PD-1 blockade
|
Cimen Bozkus, Cansu
|
|
|
39 |
9 |
p. 1187-1189
|
article
|
| 16 |
Tumor organoids: Opportunities and challenges to guide precision medicine
|
Veninga, Vivien
|
|
|
39 |
9 |
p. 1190-1201
|
article
|
| 17 |
Two opposing sub-populations of fibroblasts decide progression of pancreatic cancer
|
Kay, Emily J.
|
|
|
39 |
9 |
p. 1175-1177
|
article
|
Journal description